Reconstructive urology and tissue engineering: Converging developmental paths.

acellular matrix graft growth factors reconstructive urology scaffold stem cells tissue engineering

Journal

Journal of tissue engineering and regenerative medicine
ISSN: 1932-7005
Titre abrégé: J Tissue Eng Regen Med
Pays: England
ID NLM: 101308490

Informations de publication

Date de publication:
03 2019
Historique:
received: 23 05 2018
revised: 23 10 2018
accepted: 17 12 2018
pubmed: 19 1 2019
medline: 11 4 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

Reconstructive urology is a complex and demanding branch of modern urology. Complicated cases, necessity of microsurgical approach, and constant exposure to urine make urinary reconstruction especially difficult. With impaired healing, excessive scarring, and recurring fibrosis, functional results are still not satisfying. For better, more successful outcomes, a novel tissue engineering technology-based solutions are being gradually investigated. The use of tissue engineering is the most promising strategy to improve results of reconstructive urology procedures due to possibility of designing organ-specific grafts. Moreover, targeted modification of healing environment by stem cells and growth factors is a unique opportunity that might bring reconstructive urology on molecular level. This review defined limitations and problems encountered in reconstructive urology and discussed relevant tissue engineering-based achievements in the field of urethra, urinary bladder, and ureter regeneration. The background justifying tissue engineering approach to urethra, urinary bladder, and ureter reconstruction was discussed. Then, the wide range of experimental methods utilising biomaterials and cell seeding was deliberated to show readers the current tools offered by tissue engineering. At the end, we characterised major challenges that are needed to be addressed before tissue entering would become standard technology in urological departments.

Identifiants

pubmed: 30658008
doi: 10.1002/term.2812
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-533

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Jan Adamowicz (J)

Chair of Urology, Department of Regenerative Medicine, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland.

Blazej Kuffel (B)

Chair of Urology, Department of Regenerative Medicine, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland.

Shane Vontelin Van Breda (SV)

Department of Biomedicine, University Hospital of Basel, Basel, Switzerland.

Marta Pokrwczynska (M)

Chair of Urology, Department of Regenerative Medicine, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland.

Tomasz Drewa (T)

Chair of Urology, Department of Regenerative Medicine, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH